Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma
Clinical trial NCT05861778 · COMPLETED
Trial details
- NCT number
- NCT05861778
- Sponsor
- Telix Pharmaceuticals (Innovations) Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2023-11-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.